OPTIMA: improving prostate cancer treatment through AI
The European Association of Urology (EAU) is co-coordinating OPTIMA: a public-private partnership of 36 partners spanning 13 countries that officially launched earlier this week.
OPTIMA's aim is to revolutionise oncology care in Europe by improving broad data access, using AI-driven technology and tools, and strengthening shared decision-making based on dynamic computer-interpretable guidelines. This all originates from OPTIMA's vision, which says that every patient should have access to the most up-to-date individualised treatments and innovative therapies. OPTIMA focusses specifically on breast, lung, and prostate cancer. It is funded by the Innovative Medicines Initiative (IMI).
Please watch the video below for a full introduction of OPTIMA. For more information, please visit the project website at www.optima-oncology.eu or follow OPTIMA on Twitter @OPTIMA_oncology.
